Search by Drug Name or NDC

    NDC 42494-0453-10 Naproxen 375 mg/1 Details

    Naproxen 375 mg/1

    Naproxen is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cameron Pharmaceuticals. The primary component is NAPROXEN.

    Product Information

    NDC 42494-0453
    Product ID 42494-453_f5d320e2-0a9e-4794-8995-d8409953b9be
    Associated GPIs
    GCN Sequence Number 018435
    GCN Sequence Number Description naproxen TABLET DR 375 MG ORAL
    HIC3 S2B
    HIC3 Description NSAIDS, CYCLOOXYGENASE INHIBITOR TYPE ANALGESICS
    GCN 61850
    HICL Sequence Number 003727
    HICL Sequence Number Description NAPROXEN
    Brand/Generic Generic
    Proprietary Name Naproxen
    Proprietary Name Suffix n/a
    Non-Proprietary Name Naproxen
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 375
    Active Ingredient Units mg/1
    Substance Name NAPROXEN
    Labeler Name Cameron Pharmaceuticals
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA091432
    Listing Certified Through 2024-12-31

    Package

    NDC 42494-0453-10 (42494045310)

    NDC Package Code 42494-453-10
    Billing NDC 42494045310
    Package 100 TABLET in 1 BOTTLE, PLASTIC (42494-453-10)
    Marketing Start Date 2023-10-06
    NDC Exclude Flag N
    Pricing Information N/A